These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 10958304)

  • 1. Fas ligand expression in thyroid follicular cells from patients with thionamide-treated Graves' disease.
    Mitsiades N; Poulaki V; Tseleni-Balafouta S; Chrousos GP; Koutras DA
    Thyroid; 2000 Jul; 10(7):527-32. PubMed ID: 10958304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Fas ligand expression in thyrocytes from patients with Graves' disease.
    Hiromatsu Y; Hoshino T; Yagita H; Koga M; Sakisaka S; Honda J; Yang D; Kayagaki N; Okumura K; Nonaka K
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2896-902. PubMed ID: 10443697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential regulation of Fas-mediated apoptosis in both thyrocyte and lymphocyte cellular compartments correlates with opposite phenotypic manifestations of autoimmune thyroid disease.
    Giordano C; Richiusa P; Bagnasco M; Pizzolanti G; Di Blasi F; Sbriglia MS; Mattina A; Pesce G; Montagna P; Capone F; Misiano G; Scorsone A; Pugliese A; Galluzzo A
    Thyroid; 2001 Mar; 11(3):233-44. PubMed ID: 11327614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the expression of Fas, FasL and Bcl-2 in the pathogenesis of autoimmune thyroid disorders.
    Chen S; Fazle Akbar SM; Zhen Z; Luo Y; Deng L; Huang H; Chen L; Li W
    Cell Mol Immunol; 2004 Jun; 1(3):224-8. PubMed ID: 16219172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fas/FasL mediated apoptosis of thyrocytes in Graves' disease.
    Sera N; Kawakami A; Nakashima T; Nakamura H; Imaizumi M; Koji T; Abe Y; Usa T; Tominaga T; Ejima E; Ashizawa K; Yokoyama N; Ishikawa N; Ito K; Eguchi K
    Clin Exp Immunol; 2001 May; 124(2):197-207. PubMed ID: 11422195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of apoptosis in endocrine autoimmunity: insights from Hashimoto's thyroiditis and Graves' disease.
    Salmaso C; Bagnasco M; Pesce G; Montagna P; Brizzolara R; Altrinetti V; Richiusa P; Galluzzo A; Giordano C
    Ann N Y Acad Sci; 2002 Jun; 966():496-501. PubMed ID: 12114310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and distribution of S-100 protein, CD83 and apoptosis-related proteins (Fas, FasL and Bcl-2) in thyroid tissues of autoimmune thyroid diseases.
    Xu WC; Chen SR; Huang JX; Zheng ZC; Chen LX; Lin JJ; Li YG
    Eur J Histochem; 2007; 51(4):291-300. PubMed ID: 18162459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T cell-mediated cytotoxicity toward thyrocytes: the importance of Fas/Fas ligand interaction inducing apoptosis of thyrocytes and the inhibitory effect of thyroid-stimulating hormone.
    Kawakami A; Matsuoka N; Tsuboi M; Koji T; Urayama S; Sera N; Hida A; Usa T; Kimura H; Yokoyama N; Nakashima T; Ishikawa N; Ito K; Kawabe Y; Eguchi K
    Lab Invest; 2000 Apr; 80(4):471-84. PubMed ID: 10780664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Analysis of Fas, FasL and Caspase-8 expression in thyroid gland in young patients with immune and non-immune thyroid diseases].
    Bossowski A; Czarnocka B; Stasiak-Barmuta A; Bardadin K; Urban M; Dadan J
    Endokrynol Pol; 2007; 58(4):303-13. PubMed ID: 18058722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion.
    Mitsiades N; Poulaki V; Mastorakos G; Tseleni-Balafouta ST; Kotoula V; Koutras DA; Tsokos M
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2924-32. PubMed ID: 10443700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
    Bossowski A; Czarnocka B; Bardadin K; Stasiak-Barmuta A; Urban M; Dadan J; Ratomski K; Bossowska A
    Autoimmunity; 2008 Mar; 41(2):163-73. PubMed ID: 18324486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytofluorometric analysis of chosen markers of apoptosis CD95/CD95L (Fas/FasL) in thyroid tissues from young patients with Graves' disease and Hashimoto's thyroiditis].
    Bossowski A; Stasiak-Barmuta A; Czarnocka B; Urban M; Łyczkowska A; Niedziela M; Bardadin K; Czerwińska J; Dadan J; Baltaziak M
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(2):83-90. PubMed ID: 16813711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apoptosis induced by FasL and TRAIL/Apo2L in the pathogenesis of thyroid diseases.
    Mitsiades N; Poulaki V; Mitsiades CS; Koutras DA; Chrousos GP
    Trends Endocrinol Metab; 2001 Nov; 12(9):384-90. PubMed ID: 11595539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyrocyte targets and effectors of autoimmunity: a role for death receptors?
    Hammond LJ; Palazzo FF; Shattock M; Goode AW; Mirakian R
    Thyroid; 2001 Oct; 11(10):919-27. PubMed ID: 11716038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas ligand is expressed in normal breast epithelial cells and is frequently up-regulated in breast cancer.
    Müllauer L; Mosberger I; Grusch M; Rudas M; Chott A
    J Pathol; 2000 Jan; 190(1):20-30. PubMed ID: 10640988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iodide-induced chemokines and genes related to immunological function in cultured human thyroid follicles in the presence of thyrotropin.
    Yamazaki K; Tanigawa K; Suzuki K; Yamada E; Yamada T; Takano K; Obara T; Sato K
    Thyroid; 2010 Jan; 20(1):67-76. PubMed ID: 20025541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas ligand is expressed on human squamous cell carcinomas of the head and neck, and it promotes apoptosis of T lymphocytes.
    Gastman BR; Atarshi Y; Reichert TE; Saito T; Balkir L; Rabinowich H; Whiteside TL
    Cancer Res; 1999 Oct; 59(20):5356-64. PubMed ID: 10537320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of Fas-mediated apoptosis of human thyroid epithelial cells by IgG from patients with Graves' disease (GD) and idiopathic myxoedema.
    Kawakami A; Eguchi K; Matsuoka N; Tsuboi M; Urayama S; Kawabe Y; Tahara K; Ishikawa N; Ito K; Nagataki S
    Clin Exp Immunol; 1997 Dec; 110(3):434-9. PubMed ID: 9409648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases.
    Bossowski A; Czarnocka B; Bardadin K; Urban M; Niedziela M; Dadan J
    Horm Res; 2008; 70(3):155-64. PubMed ID: 18663316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased serum soluble Fas in patients with Graves' disease.
    Hiromatsu Y; Bednarczuk T; Soyejima E; Miyake I; Yang D; Fukazawa H; Nonaka K
    Thyroid; 1999 Apr; 9(4):341-5. PubMed ID: 10319938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.